Article info
PDFOriginal articles
A new paradigm for developing drugs in children: atomoxetine as a model
- Correspondence to:
Dr S Prasad
Lilly House, Eli Lilly and Company, Priestley Road, Basingstoke, Hampshire RG24 9NL, UK; suyashlilly.com
Citation
A new paradigm for developing drugs in children: atomoxetine as a model
Publication history
- First published January 21, 2005.
Online issue publication
January 09, 2022
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Copyright 2005 Archives of Disease in Childhood